ERBLOC Trademark
ERBLOC is a USPTO trademark filed by ImClone Systems Incorporated. Status: Abandoned.
Prosecution Summary
Trademark Summary
The mark ERBLOC covers pharmaceutical preparation, namely monoclonal antibody for the treatment of cancer. The application is currently abandoned (abandoned because no Statement of Use or Extension Request was timely filed after a Notice of Allowance was issued). The owner is ImClone Systems Incorporated. No active legal proceedings are listed.
Recent Activity
The application was filed on March 11, 2004, and the mark was published for opposition on December 21, 2004. A Notice of Allowance was issued on March 15, 2005, and the application was abandoned on March 17, 2008 after no timely Statement of Use or Extension Request was filed.
Trademark Facts
| Mark | ERBLOC |
|---|---|
| Serial Number | 76581123 |
| Status | Abandoned |
| Filing Date | 2004-03-11 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | ImClone Systems Incorporated |
| Attorney of Record | Robert M. Kunstadt |
| Prosecution Events | 28 |
| Latest Event | MAB6 on 2008-05-22 |
Goods & Services
PHARMACEUTICAL PREPARATION, NAMELY MONOCLONAL ANTIBODY FOR THE TREATMENT OF CANCER